@Steini, CHM has four IND clinical trials underway.
CLTX and NK platform already have preliminary clinical data. Safety and efficacy looks very promising!
Whereas for CDH17, prelim data is imminent.
So we have multiple shots on goal, with a significant amount of safety and efficacy clinical data available. Significantly de-risks the company right?
- Forums
- ASX - By Stock
- Comparative Analysis
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

@Steini, CHM has four IND clinical trials underway. CLTX and NK...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $100 | 25K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
28 | 21874000 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 19510638 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
28 | 21874000 | 0.004 |
37 | 23631939 | 0.003 |
15 | 13500507 | 0.002 |
9 | 49600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 19510638 | 27 |
0.006 | 23500718 | 17 |
0.007 | 4700000 | 4 |
0.008 | 8542434 | 6 |
0.009 | 2767672 | 5 |
Last trade - 15.25pm 17/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
RC1
REDCASTLE RESOURCES LIMITED
Ronald Miller, Non-Executive Director
Ronald Miller
Non-Executive Director
SPONSORED BY The Market Online